Folate (Vitamin B9): Clinical Evidence & Substantiation Summary

Clinical Trials
94
Strongest Evidence
Prenatal Health
Typical Dosage
400–1,000 mcg DFE/day
Common Forms
5-MTHF (L-methylfolate)

What Is Folate (Vitamin B9)?

Folate is a water-soluble B vitamin essential for DNA synthesis, cell division, and amino acid metabolism. It is especially critical during pregnancy for neural tube development. The active form, 5-MTHF (methylfolate), bypasses the need for MTHFR enzyme conversion.

Mechanism of action: Folate serves as a one-carbon donor in methylation reactions critical for DNA synthesis (thymidylate and purine production), amino acid metabolism (homocysteine to methionine conversion), and epigenetic regulation. The MTHFR gene polymorphism (C677T) affects folate metabolism in approximately 10–15% of the population.

Clinical Evidence Summary

Below are 5 key clinical studies on Folate (Vitamin B9). Nutra Comp analyses 94+ studies in its full clinical evidence report.

Cochrane meta-analysis2013PMID: 23440782

Folic acid supplementation and neural tube defect prevention

Population: 5 RCTs, 6,105 women

Key finding: Folic acid supplementation before conception and during early pregnancy reduced neural tube defect risk by 72% (RR 0.28, 95% CI 0.15–0.52).

Meta-analysis2020PMID: 32268543

Folate and homocysteine: a dose-response meta-analysis

Population: 25 RCTs

Key finding: Folate supplementation reduced homocysteine by 25% on average (p<0.001), with 5-MTHF showing superior effects in MTHFR C677T carriers.

5-MTHF vs folic acid: comparative efficacy

Population: 144 women

Key finding: 5-MTHF increased red blood cell folate more effectively than folic acid in women with MTHFR polymorphism (p=0.02).

Meta-analysis2018PMID: 29610056

Folate and cardiovascular risk reduction

Population: 30 RCTs

Key finding: Folic acid supplementation reduced stroke risk by 10% (RR 0.90, 95% CI 0.84–0.97), with greater effects in regions without mandatory fortification.

Systematic review2019PMID: 31433477

Folate and depression: a systematic review

Population: 11 studies

Key finding: Low folate status was associated with increased depression risk. Supplementation with methylfolate showed adjunctive benefits in treatment-resistant depression.

Evidence-Based Structure–Function Claims

Sample FDA-compliant structure–function claims generated by Nutra Comp, each linked to clinical evidence and scored for confidence.

10
Supports healthy cell division and DNA synthesis
Category: Cell Health · Confidence: 10/10
9
Supports healthy homocysteine levels already within the normal range
Category: Cardiovascular · Confidence: 9/10
10
Supports healthy prenatal development when taken before and during pregnancy
Category: Prenatal · Confidence: 10/10

Get the full substantiation report for Folate (Vitamin B9)

Includes all 94+ clinical studies analysed, complete claims library, and a ready-to-file substantiation memo.

Join Waitlist for Full Access

Related Ingredients

Iron
112 studies · Energy & Vitality
Vitamin B12
89 studies · Nervous System Support
Vitamin B6
56 studies · Mood & Neurotransmitter Support

Key Terms

BioavailabilityDaily Value (DV)Clinically Effective Dose

Frequently Asked Questions

Is folate FDA approved?

Folate is an essential B vitamin sold as a dietary supplement. The FDA has established a Daily Value of 400 mcg DFE. Folic acid in prenatal supplements is widely recommended by health organisations.

What is the difference between folic acid and methylfolate?

Folic acid is the synthetic form that must be converted to 5-MTHF by the MTHFR enzyme. Methylfolate (5-MTHF) is the active form that bypasses this conversion, beneficial for those with MTHFR gene variants affecting enzyme efficiency.

What dosage of folate is used in clinical studies?

The DV is 400 mcg DFE. Prenatal doses are typically 400–800 mcg. Higher doses (1,000–15,000 mcg) of methylfolate have been studied for mood support, particularly in treatment-resistant depression.

Stop Spending Weeks on Substantiation

Nutra Comp generates full clinical evidence reports, FDA-compliant structure–function claims, and substantiation memos in minutes — not months.

Join the Waitlist